Cervical Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who were 18 years of age or older when they were diagnosed
- People who have had a tissue sample (biopsy) or a small surgical procedure confirm a cervical cell change called CIN2
- People who have a known HPV (Human Papillomavirus) test result from the time of their diagnosis
- People who are able to understand and sign a consent form agreeing to take part in the trial
- People who have provided written consent to participate
Who may not be able to join:
- People whose HPV test result from the time of diagnosis is unknown or unavailable
- People who are considered "vulnerable patients" (confirm with trial site for the specific definition used)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Anna Daniela Iacobone, European Institute of Oncology
Phone: +39 0294371088
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Evaluation of methylation of the host cell genes FAM19A4 and miR124-2
Can't join this trial?
Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.